Experimental Pain Sensitivity in Subjects with Temporomandibular Disorders and Multiple Other Chronic Pain Conditions: The OPPERA Prospective Cohort Study

Aims: To investigate associations between experimental pain sensitivity and five chronic pain conditions among 655 participants in the OPPERA study. Methods: Quantitative sensory tests were used to measure sensitivity to three modalities of nociception: blunt pressure pain, mechanical pinprick pain, and thermal heat pain. Participants were also classified according to the presence or absence of five chronic pain conditions: temporomandibular disorders, headache, low back pain, irritable bowel syndrome, and fibromyalgia. Results: Univariate analyses found each modality to be significantly associated with at least one pain condition, most consistently for pressure pain sensitivity (8 of 15 instances) and least consistently for heat pain sensitivity (5 of 35 instances). Yet, multivariable analyses that evaluated the independent contributions of all five pain conditions found few significant associations (12 of 75 instances). Instead, pain sensitivity consistently varied according to the total number of pain conditions a person experienced, implying that the combination of pain conditions influences each nociceptive modality. Conclusion: When evaluating nociceptive sensitivity in a chronic pain patient, comorbid pain conditions should be considered, as the more salient feature underlying sensitivity is likely the number rather than the type(s) of pain conditions.

chronic overlapping pain conditions; heat pain; pinprick pain; pressure pain; quantitative sensory testing

1. Diatchenko L, Fillingim RB, Smith SB, Maixner W. The pheno-typic and genetic signatures of common musculoskeletal pain conditions. Nat Rev Rheumatol 2013;9:340–350.

2. Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: Implications for diagnosis and classification. J Pain 2016;17(9 suppl):T93–T107.

3. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states—Maybe it is all in their head. Best Pract Res Clin Rheumatol 2011;25:141–154.

4. NIH Working Group. Chronic Overlapping Pain Conditions. Summary of NIH Work Group Meeting to Develop Case Definition & Common Data Elements. National Institutes of Health, 2015.

5. Arendt-Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain 2018;22:216–241.

6. Eller-Smith OC, Nicol AL, Christianson JA. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci 2018;12:35.

7. Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 2011;152(3 suppl):s2–s15.

8. Oono Y, Wang K, Baad-Hansen L, et al. Conditioned pain modulation in temporomandibular disorders (TMD) pain patients. Exp Brain Res 2014;232:3111–3119.

9. Quartana PJ, Finan PH, Smith MT. Evidence for sustained mechanical pain sensitization in women with chronic temporo-mandibular disorder vs healthy female participants. J Pain 2015; 16:1127–1135.

10. Beese LC, Putzer D, Osada N, Evers S, Marziniak M. Contact heat evoked potentials and habituation measured interictally in migraineurs. J Headache Pain 2015;16:1.

11. Nahman-Averbuch H, Shefi T, Schneider VJ 2nd, et al. Quanti-tative sensory testing in patients with migraine: A systematic review and meta-analysis. Pain 2018;159:1202–1223.

12. Jarrett ME, Han CJ, Cain KC, et al. Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome. Neurogastroenterol Motil 2016;28:1094–1103.

13. Zhou Q, Fillingim RB, Riley JL 3rd, Malarkey WB, Verne GN. Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 2010;148:454–461.

14. Starkweather AR, Ramesh D, Lyon DE, et al. Acute low back pain: Differential somatosensory function and gene expression compared with healthy no-pain controls. Clin J Pain 2016; 32:933–939.

15. Hübscher M, Moloney N, Rebbeck T, Traeger A, Refshauge KM. Contributions of mood, pain catastrophizing, and cold hyperalgesia in acute and chronic low back pain: A comparison with pain-free controls. Clin J Pain 2014;30:886–893.

16. Hermans L, Nijs J, Calders P, et al. Influence of morphine and naloxone on pain modulation in rheumatoid arthritis, chronic fatigue syndrome/fibromyalgia, and controls: A double-blind, randomized, placebo-controlled, cross-over study. Pain Pract 2018;18:418–430.

17. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int J Surg 2014;12:1495–1499.

18. Bair E, Brownstein NC, Ohrbach R, et al. Study protocol, sample characteristics, and loss to follow-up: The OPPERA pro-spective cohort study. J Pain 2013;14(12 suppl):T2–T19.

19. Slade GD, Bair E, By K, et al. Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain 2011;12(11 suppl):T12–T26.

20. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

21. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

22. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine valida-tion study. Neurology 2003;61:375–382.

23. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastro-enterology 2006;130:1480–1491.

24. Dionne CE, Dunn KM, Croft PR, et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33:95–103.

25. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160–172.

26. Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: A comprehensive protocol for clinical trials. Eur J Pain 2006;10:77–88.

27. Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses of case-control data for additional outcomes. Epidemiology 2007;18:441–445.

28. Monsees GM, Tamimi RM, Kraft P. Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol 2009;33:717–728.

29. Tang F, Ishwaran H. Random forest missing data algorithms. Stat Anal Data Min 2017;10:363–377.

30. Fernández-Delgado M, Cernadas E, Barro S, Amorim D. Do we need hundreds of classifiers to solve real world classification problems? J Machine Learning Res 2014;15:3133–3181.

31. Greenspan JD, Slade GD, Bair E, et al. Pain sensitivity risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case control study. J Pain 2011;12(11 suppl):T61–T74.

32. Chaves TC, Dach F, Florencio LL, et al. Concomitant migraine and temporomandibular disorders are associated with higher heat pain hyperalgesia and cephalic cutaneous allodynia. Clin J Pain 2016;32:882–888.

33. Garrett PH, Sarlani E, Grace EG, Greenspan JD. Chronic tem-poromandibular disorders are not necessarily associated with a compromised endogenous analgesic system. J Orofac Pain 2013;27:142–150.

34. Carvalho GF, Chaves TC, Florencio LL, Dach F, Bigal ME, Bevilaqua-Grossi D. Reduced thermal threshold in patients with temporomandibular disorders. J Oral Rehabil 2016;43: 401–408.

35. Kothari SF, Baad-Hansen L, Oono Y, Svensson P. Somato-sensory assessment and conditioned pain modulation in temporomandibular disorders pain patients. Pain 2015;156: 2545–2555.

36. Martínez-Jauand M, Sitges C, Rodriguez V, et al. Pain sensitivity in fibromyalgia is associated with catechol-O-methyltrans-ferase (COMT) gene. Eur J Pain 2013;17:16–27.

37. Ickmans K, Meeus M, De Kooning M, Lambrecht L, Pattyn N, Nijs J. Associations between cognitive performance and pain in chronic fatigue ayndrome: Comorbidity with fibromyalgia does matter. Pain Physician 2015;18:E841–E852.

38. Schreiber KL, Loggia ML, Kim J, Cahalan CM, Napadow V, Edwards RR. Painful after-sensations in fibromyalgia are linked to catastrophizing and differences in brain response in the me-dial temporal lobe. J Pain 2017;18:855–867.

39. da Silva LA, Kazyiama HH, Teixeira MJ, de Siqueira SR. Quantitative sensory testing in fibromyalgia and hemisensory syndrome: Comparison with controls. Rheumatol Int 2013;33: 2009–2017.

40. Chalaye P, Lafrenaye S, Goffaux P, Marchand S. The role of cardiovascular activity in fibromyalgia and conditioned pain modulation. Pain 2014;155:1064–1069.

41. Crettaz B, Marziniak M, Willeke P, et al. Stress-induced allodynia— Evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress. PLoS One 2013;8:e69460.

42. Desmeules J, Chabert J, Rebsamen M, et al. Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia. J Pain 2014;15:129–135.

43. Potvin S, Marchand S. Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy con-trols. Pain 2016;157:1704–1710.

44. Piché M, Arsenault M, Poitras P, Rainville P, Bouin M. Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain 2010;148:49–58.

45. Zhou Q, Fillingim RB, Riley JL 3rd, Verne GN. Thermal hyper-sensitivity in a subset of irritable bowel syndrome patients. World J Gastroenterol 2009;15:3254–3260.

46. Rodrigues AC, Nicholas Verne G, Schmidt S, Mauderli AP. Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome. Pain 2005;115:5–11.

47. Heymen S, Maixner W, Whitehead WE, Klatzkin RR, Mechlin B, Light KC. Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clin J Pain 2010;26:104–109.

48. Verne GN, Price DD, Callam CS, Zhang B, Peck J, Zhou Q. Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors. J Pain 2012;13: 901–909.

49. Wong F, Rodrigues AC, King CD, et al. Relationships between irritable bowel syndrome pain, skin temperature indices of autonomic dysregulation, and sensitivity to thermal cutaneous stimulation. Pain Res Treat 2010;2010:949027.

50. Corrêa JB, Costa LO, de Oliveira NT, Sluka KA, Liebano RE. Central sensitization and changes in conditioned pain modulation in people with chronic nonspecific low back pain: A case-control study. Exp Brain Res 2015;233:2391–2399.

51. Klyne DM, Moseley GL, Sterling M, Barbe MF, Hodges PW. Individual variation in pain sensitivity and conditioned pain modulation in acute low back pain: Effect of stimulus type, sleep, psychological and lifestyle factors. J Pain 2018;19:942. e1.e18

52. Owens MA, Bulls HW, Trost Z, et al. An examination of pain catastrophizing and endogenous pain modulatory processes in adults with chronic low back pain. Pain Med 2016; 17:1452–1464.

53. Dahan H, Shir Y, Velly A, Allison P. Specific and number of comorbidities are associated with increased levels of temporo-mandibular pain intensity and duration. J Headache Pain 2015;16:528.